PointellisTM provides the information exchange infrastructure to help enable safe and accurate delivery of cell and gene therapies (CGT) to patients at the right time and place, every time.  

What EY can do for you

EY PointellisTM, is a solution that reimagines the biopharma supply chain, and its processes and tools, to help provide patients with groundbreaking cell and gene therapies, in the timeliest way possible.

How EY teams can help the cell and gene therapy community

The EY teams are working with people and organizations in health, life sciences, logistics and other sectors to continue to develop Pointellis™ — an information exchange platform that collects and shares data in a way that benefits all participants in the CGT ecosystem, and in an environment they can all trust.

The challenges of scaling emerging therapies

Breakthrough discoveries in cell and gene therapies offer new hope to people with a range of diseases. But how do we make them available to every patient and family that can benefit?

Cell and gene therapies are changing people’s lives, but the way they’re delivered today, through the existing CGT ecosystem, won’t scale. The only way to make cell and gene therapies a reality at scale is to create an ecosystem of different organizations working together and sharing data and information they all trust.

No single player, regardless of funding, can do this on its own.

It will require a total transformation in the way we exchange data with players across the CGT value chain, in unprecedented ways.

This means connecting every individual and organization with a stake in the patient’s care to a platform of securely shared data and information — from the nurse taking a tissue sample, to the truck driver who delivers it to a lab and the patient who is waiting for their finished treatment, to the health care provider that administers it, the payer that funds it and the regulator that oversees it.

They all need to be on the same page, working together, with data they can trust.

Why EY?

The EY organization is already a part of the ecosystem needed to make it happen. The EY professionals are working with leaders in health, life sciences, logistics and other sectors to continue to develop Pointellis™. This information platform will be critical to the widespread adoption of these breakthrough medicines.

An ecosystem with Pointellis™ at its core will have the capabilities, services and analytics needed to revolutionize patient outcomes, at scale.

Robust, compliant and secure information provided through Pointellis™ will allow each value chain participant to focus on executing their important roles in the treatment journey:

  • Patients will better understand where their treatment is through their own patient-support application.
  • Physicians will have up-to-date information of the patient’s therapy status in order to make timely care decisions.
  • Case workers can track and trace patient tissues, blood samples and finished therapies all the way through the treatment process.
  • Manufacturers are able to optimize their manufacturing capacity so as many patients as possible can receive treatment.

At EY, we want to help make cell and gene therapies available to every person and family that can benefit. By doing what EY teams do best — harnessing the transforming power of data, technology and stewardship of information — we can allow everyone else in the ecosystem to focus on what they do best, from developing new science, to delivering outstanding logistics, to giving patients the  best medical care possible.

This is how we’re building a better working world.

Case Study
The better the question The better the answer The better the world works
Case Study

Case study: How tax technology established future-state tax and finance operations for a pharma major

The company reimagined its future by leveraging technology and talent for its India operations.

Case Study
The better the question The better the answer The better the world works
Case Study

As a start-up, where do you want to end up?

The company wanted a futureproof and scalable system to manage accounting, payroll and tax processes.

A multinational specialty pharmaceutical group, headquartered in Europe, had recently set-up its business in India. As a start-up in the pharma sector in India, the company had limited visibility on the ever-changing and complex tax, compliance and regulatory environment surrounding the business.

With growing digitalization of tax and finance compliances across the globe and in India, the company was looking at a solution that leveraged digital solutions to help them in driving long-term efficiencies and agility in their tax and finance functions.

Further, given that the scale of operations for the client was likely to increase over the years, they needed a scalable and futureproof framework capable of risk-managed compliances.

To this extent, the client was seeking a trusted business advisor with strong industry and domain knowledge to help them in setting-up and running their accounting, payroll, and tax processes.

Tax solutions in newly established India operations
Case Study
The better the question The better the answer The better the world works
Case Study

We integrated multiple tax and finance processes into one solution

Through a technology driven delivery model, the company could re-imagine its future-state tax and finance function.

The pharma company was looking at employing an integrated solution which could help them with the following:

  • Setting-up and operating the accounting, payroll and tax processes by leveraging subject matter expertise and deep industry knowledge.
  • Establishing a robust governance framework that enables timely and risk-managed compliance, complete visibility, and continued quality improvements.
  • Delivering tax and finance compliance efficiencies through a digital solution and ensure that the organization was prepared to respond to the digitalization of administrations.

We built and provided an integrated finance-tax offering as a single service provider to the client. Under this offering, EY supported the organization across the spectrum of their accounting, payroll and tax requirements, including corporate tax, indirect tax compliances, routine tax audit and statutory audit support and tax advisory work.

Based on the identified themes, we helped the client build a strategic tax and finance function, with industry leading practices, through the following:

EY’s client engagement team working with the international pharma company
End-to-end accounting, payroll & tax compliance support
Case Study
The better the question The better the answer The better the world works
Case Study

Our solutions and market expertise are enabling growth and strategic expansion

We are helping unlock long-term efficiencies through robust governance, skill set integration, sector knowledge and experience.

With EY managing accounting, payroll and tax processes, the organization could focus on growing its operations in India and strategic initiatives. The organization realized that it could effectively navigate changes in the highly dynamic tax and regulatory environment, including matters such as emerging digital tax filing requirements.

We created a large impact for the company through the following key levers:

  • Robust governance and delivery framework

    aided by EY’s suite of digital solutions, to ensure quality reporting, timely and risk managed compliances, and adherence to strict data confidentiality norms.

  • Seamless co-ordination and integration

    across multiple skillsets and borders through a cohesive tax-finance service delivery model, including direct tax, indirect tax, accounting and bookkeeping and payroll, delivered through a cohesive tax-finance service delivery model, and strong teaming across borders.

  • In-depth sector knowledge

    demonstrated through the firm and the team’s experience, which helped the client visualize what they need to prepare for in terms of their newly set-up operations in India as well as our approach of adding value beyond the outsourcing engagement.

  • Leveraging EY’s market leading practice

    in the Life Sciences sector and tax and finance outsourcing space, leading to a cost-effective solution for the company.

EY’s solutions and services help organizations starting up in India establish their operations across multiple functions backed by deep industry expertise and skills.

Access the latest 'Reimagining the tax function' survey report.
Best-in-class tax solutions

Safe, accurate delivery of individualized cell and gene therapies

EY launches PointellisTM to enable the delivery of individualized cell and gene therapies to patients as personal as the therapies themselves.


Discover more

Contact us

Like what you’ve seen? Get in touch to learn more.